1. Home
  2. NGNE vs HNST Comparison

NGNE vs HNST Comparison

Compare NGNE & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$20.61

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

HOLD

Current Price

$2.64

Market Cap

303.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGNE
HNST
Founded
2003
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
327.8M
303.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NGNE
HNST
Price
$20.61
$2.64
Analyst Decision
Strong Buy
Hold
Analyst Count
6
2
Target Price
$38.50
$3.00
AVG Volume (30 Days)
188.3K
2.1M
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
N/A
$383,117,000.00
Revenue This Year
N/A
$0.03
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$42.43
Revenue Growth
N/A
3.89
52 Week Low
$6.88
$2.31
52 Week High
$37.27
$7.13

Technical Indicators

Market Signals
Indicator
NGNE
HNST
Relative Strength Index (RSI) 47.11 41.83
Support Level $19.28 $2.57
Resistance Level $22.99 $2.76
Average True Range (ATR) 1.44 0.11
MACD 0.32 -0.01
Stochastic Oscillator 40.15 17.07

Price Performance

Historical Comparison
NGNE
HNST

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

About HNST The Honest Company Inc.

The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

Share on Social Networks: